84
Views
0
CrossRef citations to date
0
Altmetric
Case reports

Rhino-Orbital Cerebral Mucormycosis in a Healthy Female Child: Case Report

, ORCID Icon, , ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 241-246 | Received 13 Dec 2023, Accepted 18 Mar 2024, Published online: 26 Mar 2024

References

  • Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clinics. 2016;30(1):143–163. doi:10.1016/j.idc.2015.10.011
  • Dong N, Jordan AE, Shen X, et al. Rhino-orbital cerebral mucormycosis in a patient with diabetic ketoacidosis: a case report and literature review. Front Neurol. 2022;13:815902. doi:10.3389/fneur.2022.815902
  • Yadav SP, Goel AK. Rhino-orbital mucormycosis—a case report. Int J Pediat Otorhinolaryngol Extra. 2010;5(1):9–12. doi:10.1016/j.pedex.2008.12.008
  • DiBartolo MA, Kelley PS. Rhino-orbital-cerebral mucormycosis (ROCM): a comprehensive case review. Aviat Space Environ Med. 2011;82:913–916. doi:10.3357/asem.3036.2011
  • Mohindra S, Mohindra S, Gupta R, Bakshi J, Gupta SK. Rhinocerebral mucormycosis: the disease spectrum in 27 patients. Mycoses. 2007;50(4):290–296. doi:10.1111/j.1439-0507.2007.01364.x
  • Weprin BE, Hall WA, Goodman J, Adams GL. Long-term survival in rhinocerebral mucormycosis. J Neurosurg. 1998;88:570–575. doi:10.3171/jns.1998.88.3.0570
  • Alabaz D, Yilmaz G, Uguz A, et al. Mucormycosis in a pediatric population: a review of 20 cases from southern Turkey, Turk. J Pediatr. 2021;63(1):11–22.
  • Hanley B, Naresh KN, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1:e245–e253. doi:10.1016/S2666-5247(20)30115-4
  • Muggeo P, Calore E, Decembrino N, et al. Invasive mucormycosis in children with cancer: a retrospective study from the Infection Working Group of Italian Pediatric Hematology Oncology Association. Mycoses. 2019;6:165–170. doi:10.1111/myc.12862
  • Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clinl Infect Dis. 2012;54(Issue suppl_1):S23–S34. doi:10.1093/cid/cir866
  • Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018;56(suppl_1):93–101. PMID: 29538730; PMCID: PMC6251532. doi:10.1093/mmy/myx101
  • Vallabhaneni S, Mody RK. Gastrointestinal mucormycosis in neonates: a review. Curr Fungal Infection Rep. 2015;9(4):269–274. doi:10.1007/s12281-015-0239-9
  • Corzo-Leon DE, Chora-Hernandez LD, Rodriguez-Zulueta P, Walsh TJ. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: epidemiology, diagnosis, and outcomes of reported cases. Med Mycol. 2017. doi:10.1093/mmy/myx017
  • Honavar SG. CodeMucor: guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol. 2021;69:1361–1365. doi:10.4103/ijo.IJO_1165_21
  • Press GA, Weindling SM, Hesselink JR, et al. Rhinocerebral mucormycosis: MR manifestations. J Comput Assist Tomogr. 1988;12:7449. doi:10.1097/00004728-198809010-00005
  • Pelton RW, Peterson E, Patel BC, Davis K. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities. Ophthalmic Plastic Reconstructive Surg. 2001;17(1):62–66. doi:10.1097/00002341-200101000-00012
  • Yohai RA, Bullock JD, Aziz AA, et al. Survival factors in rhino-orbital-cerebral mucormycosis. SurvOphthalmol. 1994;39:3–22.
  • Ferguson BJ. Mucormycosis of the nose and paranasal sinuses, Otolaryngol. Clin North Am. 2000;33:349–365.